DUBLIN, January 27, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/n68kp7/pediatric_drugs) has announced the addition of the "Pediatric Drugs and Vaccines - Global Strategic Business Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs, and Other Pediatric Drugs. The market for 'Pediatric Vaccines' in this report is analyzed by the following Type: Combinations, Hepatitis, MMR, Varicella, Poliovirus, Pneumococcal, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 120 companies including many key and niche players.
Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Advertisement
Research and Markets (http://www.researchandmarkets.com/research/n68kp7/pediatric_drugs) has announced the addition of the "Pediatric Drugs and Vaccines - Global Strategic Business Report" report to their offering.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs, and Other Pediatric Drugs. The market for 'Pediatric Vaccines' in this report is analyzed by the following Type: Combinations, Hepatitis, MMR, Varicella, Poliovirus, Pneumococcal, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 120 companies including many key and niche players.
Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Actelion Pharmaceuticals Ltd (Switzerland)
- Abbott Laboratories (US)
- Allergan, Inc. (US)
- Amgen, Inc. (US)
- AstraZeneca Plc. (UK)
- Boehringer Ingelheim GmbH (Germany)
- Bristol-Myers Squibb Company (US)
- Crucell N.V. (The Netherlands)
- Eli Lilly and Company (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Genentech, Inc. (US)
- GlaxoSmithKline plc. (UK)
- InfaCare, Inc. (USA)
- Merck & Co., Inc. (US)
- Merck Serono (Switzerland)
- Novartis AG (Switzerland)
- Novo Nordisk A/S (Denmark)
- Pfizer, Inc. (US)
- Sanofi S.A (formerly Sanofi-Aventis) (France)
- Shionogi Inc. (US)
- Shire Pharmaceuticals Group Plc (UK)
- The United States (78)
- Canada (4)
- Japan (5)
- Europe (35)
- France (4)
- Germany (4)
- The United Kingdom (5)
- Rest of Europe (22)
- Asia-Pacific (Excluding Japan) (8)
- Latin America (1)
- Actelion Pharmaceuticals Ltd.
- Abbott Laboratories
- Allergan, Inc.
- Amgen, Inc.
- AstraZeneca Plc
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets